Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kendra C Foley

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Melanoma Research|March 10, 2018
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanomaKendra C Foley, Michael I Nishimura, Tamson V Moore
Journal of Leukocyte Biology|January 20, 2018
TCR modifications that enhance chain pairing in gene-modified T cells can augment cross-reactivity and alleviate CD8 dependenceTimothy T Spear, Kendra C Foley, Elizabeth Garrett-Mayer, et al.
Molecular Therapy Oncolytics|June 3, 2017
HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive TransferKendra C Foley, Timothy T Spear, David C Murray, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2017
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cellsTimothy T Spear, Yuan Wang, Kendra C Foley, et al.
Cell Reports Methods|May 13, 2025
Generation of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discoveryBrandon P Conn, Jared L Dietze, Christian J Yee, et al.
Nature Chemical Biology|September 19, 2018
T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptabilityTimothy P Riley, Lance M Hellman, Marvin H Gee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2019
Improving T Cell Receptor On-Target Specificity via Structure-Guided DesignLance M Hellman, Kendra C Foley, Nishant K Singh, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.
Journal of Leukocyte Biology|February 28, 2016
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instabilityTimothy T Spear, Timothy P Riley, Gretchen E Lyons, et al.
Cell Reports Methods|April 27, 2022
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Scott P Goulding, Brandon P Conn, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Melanoma Research|March 10, 2018
Combination immunotherapies implementing adoptive T-cell transfer for advanced-stage melanomaKendra C Foley, Michael I Nishimura, Tamson V Moore
Journal of Leukocyte Biology|January 20, 2018
TCR modifications that enhance chain pairing in gene-modified T cells can augment cross-reactivity and alleviate CD8 dependenceTimothy T Spear, Kendra C Foley, Elizabeth Garrett-Mayer, et al.
Molecular Therapy Oncolytics|June 3, 2017
HCV T Cell Receptor Chain Modifications to Enhance Expression, Pairing, and Antigen Recognition in T Cells for Adoptive TransferKendra C Foley, Timothy T Spear, David C Murray, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2017
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cellsTimothy T Spear, Yuan Wang, Kendra C Foley, et al.
Cell Reports Methods|May 13, 2025
Generation of T cell responses against broad KRAS hotspot neoantigens for cell therapy or TCR discoveryBrandon P Conn, Jared L Dietze, Christian J Yee, et al.
Nature Chemical Biology|September 19, 2018
T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptabilityTimothy P Riley, Lance M Hellman, Marvin H Gee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2019
Improving T Cell Receptor On-Target Specificity via Structure-Guided DesignLance M Hellman, Kendra C Foley, Nishant K Singh, et al.
Cancer Immunology, Immunotherapy : CII|February 5, 2016
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsTimothy T Spear, Glenda G Callender, Jeffrey J Roszkowski, et al.
Journal of Leukocyte Biology|February 28, 2016
Hepatitis C virus-cross-reactive TCR gene-modified T cells: a model for immunotherapy against diseases with genomic instabilityTimothy T Spear, Timothy P Riley, Gretchen E Lyons, et al.
Cell Reports Methods|April 27, 2022
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutationsJaewon Choi, Scott P Goulding, Brandon P Conn, et al.
Pageof 1